1. Home
  2. MBOT vs TCRX Comparison

MBOT vs TCRX Comparison

Compare MBOT & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • TCRX
  • Stock Information
  • Founded
  • MBOT 2010
  • TCRX 2018
  • Country
  • MBOT United States
  • TCRX United States
  • Employees
  • MBOT N/A
  • TCRX N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • TCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBOT Health Care
  • TCRX Health Care
  • Exchange
  • MBOT Nasdaq
  • TCRX Nasdaq
  • Market Cap
  • MBOT 94.6M
  • TCRX 82.1M
  • IPO Year
  • MBOT N/A
  • TCRX 2021
  • Fundamental
  • Price
  • MBOT $2.60
  • TCRX $1.81
  • Analyst Decision
  • MBOT Strong Buy
  • TCRX Strong Buy
  • Analyst Count
  • MBOT 1
  • TCRX 6
  • Target Price
  • MBOT $9.00
  • TCRX $9.50
  • AVG Volume (30 Days)
  • MBOT 1.0M
  • TCRX 628.8K
  • Earning Date
  • MBOT 08-13-2025
  • TCRX 08-11-2025
  • Dividend Yield
  • MBOT N/A
  • TCRX N/A
  • EPS Growth
  • MBOT N/A
  • TCRX N/A
  • EPS
  • MBOT N/A
  • TCRX N/A
  • Revenue
  • MBOT N/A
  • TCRX $4,421,000.00
  • Revenue This Year
  • MBOT N/A
  • TCRX $159.20
  • Revenue Next Year
  • MBOT N/A
  • TCRX N/A
  • P/E Ratio
  • MBOT N/A
  • TCRX N/A
  • Revenue Growth
  • MBOT N/A
  • TCRX N/A
  • 52 Week Low
  • MBOT $0.82
  • TCRX $1.02
  • 52 Week High
  • MBOT $3.38
  • TCRX $7.89
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 54.60
  • TCRX 62.32
  • Support Level
  • MBOT $2.44
  • TCRX $1.45
  • Resistance Level
  • MBOT $2.77
  • TCRX $1.90
  • Average True Range (ATR)
  • MBOT 0.13
  • TCRX 0.14
  • MACD
  • MBOT 0.01
  • TCRX 0.04
  • Stochastic Oscillator
  • MBOT 63.83
  • TCRX 82.00

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: